Marie Aliette Dommergues

Toward a simplified vaccination schedule in France: How can the tools we possess be put to better use?

Robert Cohen, Odile Launay, Catherine Weil-Olivier, P. Bakhache et autres

fr (code pays fourni par la source)

Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase–producing Enterobacteriaceae in children: A French multicenter study

Gabriel Lignieres, André Birgy, Camille Jung, Stéphane Bonacorsi et autres

OBJECTIVES: We need studies assessing therapeutic options for oral relay in febrile urinary tract infection (FUTI) due to ESBL-producing Enterobacteriaceae (ESBL-E) in children. Amoxicillin-clavulanate/cefixime (AC-cefixime) combination seems to be a suitable option. We sought to describe the risk of recurrence at 1 …

fr (code pays fourni par la source)

Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation

Fouad Madhi, Corinne Lévy, Laurence Morin, Philippe Minodier et autres

We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection …

fr (code pays fourni par la source)

Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey

Naïm Ouldali, Corinne Lévy, Emmanuelle Varon, Stéphane Bonacorsi et autres

fr (code pays fourni par la source)

Impact of PCV13 on community-acquired pneumonia by C-reactive protein and procalcitonin levels in children

Corinne Lévy, Sandra Biscardi, Marie Aliette Dommergues, François Dubos et autres

fr (code pays fourni par la source)

Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children

François Angoulvant, Corinne Lévy, E. Grimprel, Emmanuelle Varon et autres

BACKGROUND: Pneumococcal serotypes 1, 3, 5, 7F, and 19A were the most implicated in community-acquired pneumonia (CAP) after implementation of 7-valent pneumococcal conjugate vaccine (PCV7). In France, the switch from PCV7 to 13-valent pneumococcal conjugate vaccine (PCV13) occurred in June 2010. An …

fr (code pays fourni par la source)